Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2019-05-07 Regulatory Filings
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2019-05-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification to stock exchanges about an upcoming earnings conference call scheduled for May 7, 2019, to discuss the audited financial results for the quarter and year ended March 31, 2019. It includes details about the call timing, participants, and dial-in numbers. The document does not contain actual financial statements or detailed financial analysis but serves as an announcement of the earnings call event. Therefore, it is classified as a Call Transcript (CT) announcement rather than the transcript itself or a financial report.
2019-05-01 English
Updates
Regulatory Filings Classification · 100% confidence The document text contains only placeholder lines and omitted pictures, with no substantive content or financial data. The true document length is only 151 characters, indicating it is extremely short and contains no report or announcement text. There is no indication of any report type, regulatory body, or financial information. Given the lack of content, the document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2019-04-30 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled for 7 May 2019. The meeting will consider the audited financial results for the quarter and year ended 31 March 2019 and the declaration of a final dividend. The document is an intimation or announcement of a board meeting and not the actual financial results or dividend declaration. It is also under 5,000 characters and serves as a regulatory announcement to comply with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a full financial report or dividend notice.
2019-04-29 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulations 30(1) & 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the shareholding of promoters and promoter groups as of 31 March 2019, including percentages of total paid-up equity capital. The content focuses on substantial acquisition of shares and takeover regulations, which aligns with notifications about major shareholding changes. There is no indication of financial statements, audit information, or other report types. The document is a regulatory disclosure about shareholding changes, fitting the category of Major Shareholding Notification (MRQ). The document length is 4278 characters, which is sufficient for a detailed notification rather than a brief announcement. Therefore, the classification is MRQ with high confidence.
2019-04-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the closure of the trading window in compliance with SEBI regulations related to insider trading. It mentions the trading window closure period around the financial results announcement date but does not contain any financial data or results itself. The document is short (1110 characters) and serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-04-03 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.